{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:51:42Z","timestamp":1780087902215,"version":"3.54.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T00:00:00Z","timestamp":1399939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096544","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T20:42:46Z","timestamp":1400013766000},"page":"e96544","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["AAV-Dominant Negative Tumor Necrosis Factor (DN-TNF) Gene Transfer to the Striatum Does Not Rescue Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Laura Taylor","family":"Alto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Ruhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mal\u00fa G.","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"ME Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"HM Gao","year":"2008","journal-title":"Trends Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"TC Frank-Cannon","year":"2009","journal-title":"Mol Neurodegener"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"T Moller","year":"2010","journal-title":"J Neural Transm"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"E Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"N Pavese","year":"2006","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"YF Tai","year":"2007","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"M Politis","year":"2011","journal-title":"Hum Brain Mapp"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"A Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"M Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease","volume":"159","author":"SK Singhrao","year":"1999","journal-title":"Exp Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"A Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"A Dalrymple","year":"2007","journal-title":"J Proteome Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/CCLM.1998.132","article-title":"Activated immune system in patients with Huntington's disease","volume":"36","author":"F Leblhuber","year":"1998","journal-title":"Clin Chem Lab Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington's disease","volume":"3","author":"E Wild","year":"2011","journal-title":"PLoS Curr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/glia.10261","article-title":"Microglia density decreases with age in a mouse model of Huntington's disease","volume":"43","author":"L Ma","year":"2003","journal-title":"Glia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","article-title":"DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6\/2) reveals neuroinflammation and insulin associations","volume":"1088","author":"SF Crocker","year":"2006","journal-title":"Brain Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"FE McAlpine","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease","volume":"26","author":"MK McCoy","year":"2006","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/mt.2008.146","article-title":"Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats","volume":"16","author":"MK McCoy","year":"2008","journal-title":"Mol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/exnr.2000.7551","article-title":"ST14A cells have properties of a medium-size spiny neuron","volume":"167","author":"ME Ehrlich","year":"2001","journal-title":"Exp Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","article-title":"IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome","volume":"187","author":"LM Thompson","year":"2009","journal-title":"J Cell Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease","volume":"100","author":"X Wang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","article-title":"Immune activation in brain aging and neurodegeneration: too much or too little?","volume":"64","author":"KM Lucin","year":"2009","journal-title":"Neuron"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2005.01.015","article-title":"Autocrine activation of microglia by tumor necrosis factor-alpha","volume":"162","author":"R Kuno","year":"2005","journal-title":"J Neuroimmunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha","volume":"20","author":"K Sriram","year":"2006","journal-title":"Faseb J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"EJ Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nbd.2008.08.006","article-title":"Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease","volume":"32","author":"C Lawhorn","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"L Menalled","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington's disease","volume":"27","author":"TS Tang","year":"2007","journal-title":"J Neurosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1523\/JNEUROSCI.4411-08.2009","article-title":"Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model","volume":"29","author":"TS Tang","year":"2009","journal-title":"J Neurosci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"JM Van Raamsdonk","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"JM Van Raamsdonk","year":"2005","journal-title":"J Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"JG Hodgson","year":"1999","journal-title":"Neuron"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbadis.2009.10.013","article-title":"Inflammation in transgenic mouse models of neurodegenerative disorders","volume":"1802","author":"C Schwab","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","article-title":"Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection","volume":"179","author":"J Zalevsky","year":"2007","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"S Zolotukhin","year":"2002","journal-title":"Methods"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"TS Tang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator","volume":"231","author":"MJ West","year":"1991","journal-title":"Anat Rec"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1081297","article-title":"Inactivation of TNF signaling by rationally designed dominant-negative TNF variants","volume":"301","author":"PM Steed","year":"2003","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/mt.2010.217","article-title":"Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease","volume":"19","author":"AS Harms","year":"2011","journal-title":"Mol Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1523\/JNEUROSCI.4846-11.2012","article-title":"Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease","volume":"32","author":"W Kwan","year":"2012","journal-title":"J Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nrmicro1266","article-title":"Precise hit: adeno-associated virus in gene targeting","volume":"3","author":"A Vasileva","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","volume":"132","author":"J Palazuelos","year":"2009","journal-title":"Brain"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice","volume":"1762","author":"EC Stack","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"M Chen","year":"2000","journal-title":"Nat Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","volume":"196","author":"HS Kim","year":"2009","journal-title":"Behav Brain Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.21-08-02580.2001","article-title":"Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia","volume":"21","author":"T Tikka","year":"2001","journal-title":"J Neurosci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"AE Cardona","year":"2006","journal-title":"Nat Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"16241","DOI":"10.1523\/JNEUROSCI.3667-11.2011","article-title":"CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity","volume":"31","author":"JT Rogers","year":"2011","journal-title":"J Neurosci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.186.10.1757","article-title":"Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor","volume":"186","author":"T Kurihara","year":"1997","journal-title":"J Exp Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e25833","DOI":"10.1371\/journal.pone.0025833","article-title":"Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis","volume":"6","author":"RR Rampersad","year":"2011","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-010-0722-x","article-title":"Contribution of systemic inflammation to chronic neurodegeneration","volume":"120","author":"VH Perry","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"S Franciosi","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/brain\/awr199","article-title":"Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination","volume":"134","author":"R Brambilla","year":"2011","journal-title":"Brain"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1471-4159.2008.05823.x","article-title":"Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction","volume":"108","author":"SK Godavarthi","year":"2009","journal-title":"J Neurochem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1172\/JCI64484","article-title":"Mutant huntingtin impairs immune cell migration in Huntington disease","volume":"122","author":"W Kwan","year":"2012","journal-title":"J Clin Invest"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1523\/JNEUROSCI.0116-08.2008","article-title":"Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5\/RANTES) by astrocytes","volume":"28","author":"SY Chou","year":"2008","journal-title":"J Neurosci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T12:16:28Z","timestamp":1565439388000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096544"}},"subtitle":[],"editor":[{"given":"Christopher Mark","family":"Norris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,13]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096544","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,13]]}}}